Mielóma multiplex: nyitott vizsgálatok itt: Kanada

49 nyitott vizsgálatnak van helyszíne itt: Kanada. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT05730036
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Kísérleti kezelés · 3. fázis · Regeneron Pharmaceuticals
The Ottawa Hospital Cancer Centre, Ottawa · Sunnybrook Health Sciences Centre, Toronto · University Health Network - Princess Margaret Cancer Center, Toronto
Regiszter frissítve: 2026-11-06
NCT05552222
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Kísérleti kezelés · 3. fázis · Janssen Research & Development, LLC
Arthur J.E. Child Comprehensive Cancer Centre, Calgary · Cross Cancer Institute, Edmonton · Lakeridge Health Oshawa, Oshawa · CHU de Quebec - L'Hôtel-Dieu de Québec, Québec · British Columbia Cancer Agency, Vancouver
Regiszter frissítve: 2026-11-03
NCT07258511
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Kísérleti kezelés · 3. fázis · Janssen Research & Development, LLC
Arthur J.E. Child Comprehensive Cancer Centre, Calgary · Queen Elizabeth II, Health Sciences Centre, Halifax · Juravinski Cancer Centre, Hamilton · London Health Sciences Centre, London · CIUSSS de l Est de l Ile de Montreal Installation Hopital Maisonneuve Rosemont, Montreal · University Health Network UHN Princess Margaret Cancer Centre, Toronto · British Columbia Cancer Agency, Vancouver
Regiszter frissítve: 2026-11-03
NCT05519085
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Kísérleti kezelés · 3. fázis · Celgene
Greenfield Park · Montreal · Québec
Regiszter frissítve: 2026-10-30
NCT06106945
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Kísérleti kezelés · 1/2. fázis · AstraZeneca
Hamilton · Montreal · Nova Scotia · Ottawa · Toronto
Regiszter frissítve: 2026-10-30
NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Kísérleti kezelés · 3. fázis · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Arthur J.E. Child Comprehensive Cancer Centre, Calgary · QEII Health Sciences Centre, Victoria General Site, Halifax · Hamilton Health Sciences-Juravinski Cancer Centre, Hamilton · CIUSSS de l'Est-de-l'Île-de-Montréal, Montreal · Vancouver General Hospital, Vancouver
Regiszter frissítve: 2026-10-29
NCT00900198
Collection of Tissue Samples for Cancer Research
Kutatás · National Cancer Institute (NCI)
Princess Margaret Hospital Cancer Centre, Toronto
Regiszter frissítve: 2026-10-27
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Kísérleti kezelés · 3. fázis · Pfizer
Arthur J.E. Child Comprehensive Cancer Centre, Calgary · Cross Cancer Institute, Edmonton · Dr. Everett Chalmers Regional Hospital, Fredericton · QEII Health Sciences Centre, Halifax · Nova Scotia Health Authority, Halifax · Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer, Sherbrooke · Princess Margaret Cancer Centre, Toronto
Regiszter frissítve: 2026-10-27
NCT04973605
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Kísérleti kezelés · 1/2. fázis · BeOne Medicines
Cross Cancer Institute, Edmonton · Princess Margaret Cancer Centre, Toronto · British Columbia Cancer Agency the Vancouver Centre, Vancouver
Regiszter frissítve: 2026-10-26
NCT06280924
Prehab Prior to Stem Cell Transplantation in Multiple Myeloma
Kísérleti kezelés · University of Alberta
University of Alberta - Cross Cancer Institute, Edmonton
Regiszter frissítve: 2026-10-23
NCT05651932
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Kísérleti kezelés · 1. fázis · K36 Therapeutics, Inc.
Cross Cancer Institute, Edmonton · University Health Network (UHN) - Princess Margaret Cancer Centre (Princess Margaret Hospital), Toronto
Regiszter frissítve: 2026-10-22
NCT07735637
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Kísérleti kezelés · 3. fázis · AstraZeneca
Calgary · Halifax · Montreal · Sherbrooke
Regiszter frissítve: 2026-10-21
NCT04910568
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Kísérleti kezelés · 1. fázis · Genentech, Inc.
Cross Cancer Institute, Edmonton · Hamilton Health Sciences, Hamilton · University Health Network, Toronto
Regiszter frissítve: 2026-10-20
NCT06182774
Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma
Kísérleti kezelés · 3. fázis · Canadian Cancer Trials Group
Royal Victoria Regional Health Centre, Barrie · William Osler Health System, Brampton · Cross Cancer Institute, Edmonton · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton · BCCA - Kelowna, Kelowna · Kingston Health Sciences Centre, Kingston · Waterloo Regional Health Network (WRHN), Kitchener · London Health Sciences Centre Research Inc., London · Trillium Health Partners - Credit Valley Hospital, Mississauga · The Moncton Hospital, Moncton · The Jewish General Hospital, Montreal · St. Mary's Hospital, Montreal · The Research Institute of the McGill University, Montreal · CIUSSS de l'Est-de-I'lle-de-Montreal, Montreal · Stronach Regional Health Centre at Southlake, Newmarket · Oakville Trafalgar Memorial Hospital, Oakville · Lakeridge Health Oshawa, Oshawa · Ottawa Hospital Research Institute, Ottawa · CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Québec · Allan Blair Cancer Centre, Regina · Regional Health Authority B, Zone 2, Saint John · Saskatoon Cancer Centre, Saskatoon · Algoma District Cancer Program, Sault Ste. Marie · Niagara Health System, St. Catharines · Dr. H. Bliss Murphy Cancer Centre, St. John's · Thunder Bay Regional Health Sciences Centre, Thunder Bay · St. Michael's Hospital, Toronto · St. Joseph's Health Centre, Toronto · BCCA - Vancouver, Vancouver · Windsor Regional Cancer Centre, Windsor · CancerCare Manitoba, Winnipeg
Regiszter frissítve: 2026-10-14
NCT07648264
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Kísérleti kezelés · 3. fázis · CSL Behring
Horizon Health Network, Fredericton · McGill University Health Research Institute, Montreal
Regiszter frissítve: 2026-10-14
NCT06980480
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Kísérleti kezelés · 3. fázis · Takeda
Centre Hospitalier de l'Université de Montréal, Montreal · Cancer Care Manitoba, Winnipeg
Regiszter frissítve: 2026-10-13
NCT07555938
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Kísérleti kezelés · 3. fázis · Hoffmann-La Roche
Hamilton Health Sciences-Juravinski Cancer Centre, Hamilton
Regiszter frissítve: 2026-10-13
NCT05243797
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Kísérleti kezelés · 3. fázis · European Myeloma Network B.V.
Cross Cancer Institute, Edmonton · QEII Health Sciences Centre, Halifax · The Ottawa General Hospital, Ottawa · Saskatoon Cancer Center, Saskatoon · Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke (CIUSSS de l'Estrie-CHUS), Sherbrooke · Princess Margaret Cancer Centre, Toronto · BC Cancer, Vancouver
Regiszter frissítve: 2026-10-07
NCT06297226
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Kísérleti kezelés · 2. fázis · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Arthur J.E. Child Comprehensive Cancer Centre, Calgary · McGill University Health Centre, Montreal
Regiszter frissítve: 2026-10-06
NCT06224309
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Kutatás · British Columbia Cancer Agency
BC Cancer, Vancouver
Regiszter frissítve: 2026-10-01
NCT06871176
PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)
Kísérleti kezelés · University Health Network, Toronto
University Health Network, Toronto
Regiszter frissítve: 2026-10-01
NCT07391657
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Kísérleti kezelés · 3. fázis · AstraZeneca
Calgary · Montreal · Toronto · Vancouver
Regiszter frissítve: 2026-09-29
NCT06421675
Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
Kísérleti kezelés · 2. fázis · Ontario Clinical Oncology Group (OCOG)
Juravinski Cancer Center, Hamilton · Kingston General Hospital, Kingston · London Health Science Centre - Victoria Hospital, London · Ottawa Hospital, Ottawa · Vancouver Cancer Center, Vancouver · BC Cancer - Victoria, Victoria
Regiszter frissítve: 2026-09-28
NCT03702309
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Kutatás · University Health Network, Toronto
Princess Margaret Cancer Centre, Toronto
Regiszter frissítve: 2026-09-25
NCT07518186
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Kísérleti kezelés · 3. fázis · Janssen Research & Development, LLC
Arthur J.E. Child Comprehensive Cancer Centre, Calgary · Cross Cancer Institute, Edmonton · Lakeridge Health Oshawa, Oshawa · Princess Margaret Hospital, Toronto
Regiszter frissítve: 2026-09-25

Minden vizsgálat (Mielóma multiplex) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek